Innovative drugs-Shenzhen New Frontier United Family Hospital

Bay Area Integration

Shenzhen New Frontier United Family Hospital, which constantly pursues excellence in the medical field, always adheres to the international and high-quality medical philosophy, and is committed to providing patients with treatment and medication plans that meet international standards, are safe, and effective. In the introduction and application of innovative drugs, the hospital strives for excellence, strictly follows high standards, and continuously enriches the list of innovative drugs to meet diversified clinical medical needs.

1.Drug selection criteria

(1) International quality priority

The original drug has undergone rigorous research and clinical trials, and its efficacy and safety have been fully validated. Innovative drugs represent the forefront of medical research and can bring new treatment hopes and better treatment outcomes to patients. The pharmacy department of the hospital selects high-quality original and innovative drugs to ensure that patients can receive safe and effective treatment.

(2) Evidence based medicine

Every innovative drug introduced must have sufficient clinical research data support. Hospitals strictly adhere to the principles of evidence-based medicine, requiring drugs to have scientific and reliable evidence in terms of efficacy and safety. Only drugs that have undergone rigorous clinical trials and proven to be effective in treating the corresponding diseases and have good safety are eligible to enter the hospital's drug catalog.

(3) Comprehensive evaluation of cost-effectiveness

On the premise of ensuring the quality of drugs, hospitals will comprehensively evaluate the cost-effectiveness of drugs. Considering the patient's financial burden and treatment effectiveness, choose a treatment plan that meets the appropriate needs of the patient. This is not only the hospital's concern for the interests of patients, but also ensures the rational utilization of medical resources.

(4) Keeping up with the international forefront

The hospital continues to pay attention to the introduction of the latest international treatment plans and actively utilizes favorable conditions such as the "Hong Kong Macau Medical Device Connect" policy to provide patients with innovative drugs that have not yet been listed in mainland China but have been approved in Hong Kong and Macau. This enables patients to benefit from the latest international medical technology and therapies in the first place, without the need to travel overseas to receive cutting-edge treatment.

2. The proportion of imported drugs and the process of introducing innovative drugs

(1) Proportion of imported drugs

The proportion of original drugs in Shenzhen New Frontier United Family Hospital is as high as 75%, covering a wide range of treatment fields such as cancer, cardiovascular disease, and anti allergy. These imported original drugs provide patients with more treatment options and better treatment guarantees due to their excellent quality and efficacy.

(2) Innovative drug introduction process

Clinical demand application: The introduction of innovative drugs begins with doctors or relevant departments submitting applications based on actual clinical needs. In the daily diagnosis and treatment process, doctors discover the limitations of existing drugs based on the patient's condition and treatment needs, and propose the introduction of innovative drugs.

Pharmacist evaluation: Pharmacists refer to the latest international treatment guidelines and conduct a comprehensive evaluation of the innovative drugs applied for introduction. The evaluation content includes the mechanism of action, efficacy, safety, and applicable population of the drug, ensuring that the drug meets the needs and standards of clinical treatment.

Hospital Pharmacy Management and Treatment Committee: The hospital pharmacy management and treatment committee conducts a comprehensive review of the efficacy, safety, and economic benefits of drugs. The committee members include doctors, pharmacists, nurses, and non clinical personnel, who conduct comprehensive evaluations of innovative drugs from different professional perspectives to ensure that the introduction of each new drug truly meets the interests of patients.

Drug procurement management: The pharmacy department has a dedicated procurement management team responsible for timely and safe procurement of innovative drugs. Ensure the quality and reliable supply of drugs, so that innovative drugs can be quickly applied in clinical practice.床。

3. Innovative drug features and clinical applications

(1) Cardiovascular field

The hospital has introduced Ingersoll Rand Inclisiran（Leqvio）， This is an innovative long-acting lipid-lowering drug. Patients only need to receive injections twice a year to achieve good lipid-lowering effects, greatly improving the medication experience for patients with hypercholesterolemia. Compared with traditional lipid-lowering drugs, Ingersoll Rand has the advantages of convenient use and long-lasting efficacy, providing a better treatment option for cardiovascular disease patients.

(2) Weight management direction

Oral Simeglutide (Novohexidine): As the world's first oral medication GLP - 1 The main agonist has brought new breakthroughs to weight management. The oral administration method improves patients' medication compliance, while effectively reducing weight and improving metabolic indicators.

Tilpotide (Mufengda): is the world's first and approved GLP - 1/GIP Dual receptor agonist. It regulates blood sugar and weight more effectively through a dual mechanism of action, providing a more powerful treatment for patients with obesity and related metabolic diseases.

Masidu Peptide (Xinermei): As the world's first and approved GCG/GLP - 1 Dual receptor agonists have unique advantages in weight management and metabolic regulation. Its innovative mechanism of action brings new hope to patients, helping to achieve healthier weight and lifestyle.

(3) Oncology Department

Advantages of centralized procurement policy: Hospitals rely on the advantages of centralized procurement policy in mainland China to provide all cancer drugs at cost price (zero markup). This measure greatly reduces the cost of medication for patients, enabling more patients to afford advanced cancer treatment drugs.

The widespread use of original drugs: In the treatment of tumors, the clinical use of original drugs is extremely prominent. For example, Lenvima, Tagrisso, Kisqali, and other drugs are widely used. These original drugs have definite efficacy and good safety in tumor treatment, which can provide more effective treatment for cancer patients, prolong survival, and improve quality of life.

Unique innovative drugs in mainland China: Patients can also conveniently use innovative drugs unique to mainland China, such as the new third-generation, at Shenzhen Xinfeng United Family Hospital EGFR Targeted drug Fumatinib (Eversa), the only globally approved drug for use EGFR Exon 20ins Oral new drugs such as sunitinib (shuvozhe) for mutated lung cancer. These drugs provide targeted treatment options for specific types of cancer patients.

(4) Cardiovascular field

The pharmacy department of the hospital actively introduces international advanced preventive drugs to further meet diversified medical needs. for example HIV The pre exposure prophylaxis (PrEP) drug ateravir (Apretude) can effectively reduce HIV The risk of infection provides an important preventive measure for high-risk populations. The recombinant herpes zoster vaccine (Shingrix) can prevent the occurrence of herpes zoster, alleviate the pain and complications caused by the disease, and is particularly suitable for susceptible populations such as middle-aged and elderly people.

The innovative drug catalog of Shenzhen New Frontier United Family Hospital continues to be updated, covering multiple fields such as internal surgery, dermatology, tumor treatment, and vaccines. In the future, the hospital will further expand the scope of introducing innovative drugs, keep up with international medical trends, and continuously optimize the drug structure. By collaborating with renowned experts and research institutions at home and abroad, actively participating in new drug research and clinical trials, we provide patients with more high-quality medical services that are synchronized with the world, helping them recover their health and improve their quality of life.